Gaudium IVF and Women Health Ltd Price Today
Gaudium IVF and Women Health Ltd share price is
₹99.44 as on
01-Jan-1980,
Up 2.09%
from the previous close of ₹97.4.
The stock has traded between
₹100.99 and
₹96.42 today,
against a 52-week range of
₹N/A to
₹N/A.
Over the past year the stock is
N/A range.
Market capitalisation stands at ₹784.28 crore.
Gaudium IVF and Women Health Ltd Shareholding Pattern
Promoter Holdings
71.292 %
FIIs
1.194 %
DIIs
2.218 %
MutualFund
0.001 %
Retail
18.191 %
Others -
7.103 %
About Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana. Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center.
The Company is engaged in providing In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), fertility preservation, and other Assisted Reproductive Technology (ART) and women's healthcare services across India, expanding its reach through a strategic alliance with infertility experts to promote awareness of ART and IVF treatments.
Its facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques. For fertility preservation, Company offer cryopreservation services for eggs freezing for future fertilization, utilizing advanced technology to ensure optimal success rates in future IVF cycles. It further provide laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders.
The Com ...pany began its journey by starting the business operations at Gaudium Hospital in 2019. Gaudium IVF and Gynae Solutions, a proprietary firm of Dr. Manika Khanna, was acquired by the Company with the main object clause, pursuant to a preferential allotment dated March 29, 2021. This acquisition was executed through the issuance of 9,40,232 equity shares.
In 2024, Company has started Srinagar Centre in Jammu & Kashmir; started Banglore Centre in Karnataka.
The Company offer a complete specialized fertility and reproductive health services. The advance treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all our treatment is carefully designed to address a variety of infertility challenges for both male and female. It also offers comprehensive gynecological care, including PCOD/PCOS and endometriosis. Further, high-risk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs, offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.
Apart from these, the facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques. For fertility preservation, Company offer cryopreservation services for eggs freezing for future fertilization, utilizing state-of-the-art technology to ensure optimal success rates in future IVF cycles. Additionally, the centers specialize in Frozen Embryo Transfers (FET). They also offer laparoscopic and hysteroscopic surgeries for diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders.
The Company came up with IPO of 2,08,86,200 equity shares of Rs 5 each by raising funds aggregating to Rs 165 crores, comprising a fresh issue of 1,13,92,500 equity shares amounting to Rs 90 crores and the offer for sale of 94,93,700 equity shares amounting to Rs 75 crores on February 24, 2026.
The first new centre at South Extension, New Delhi became operational from July 16, 2026.
1. Can I buy Gaudium IVF and Women Health Ltd from PL Capital? ›
Yes, you can invest in Gaudium IVF and Women Health Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Gaudium IVF and Women Health Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Gaudium IVF and Women Health Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Gaudium IVF and Women Health Ltd pay dividends? ›
Gaudium IVF and Women Health Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Gaudium IVF and Women Health Ltd ? ›
As of
01-Jan-1980 , 00:00:00 the share price for Gaudium IVF and Women Health Ltd. is ₹ 99.44 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Gaudium IVF and Women Health Ltd ? ›
The 52-week high and low of Gaudium IVF and Women Health Ltd share price is ₹ - ₹ as of
01-Jan-1980 , 00:00:00 .
5. What is the market capitalisation of Gaudium IVF and Women Health Ltd? ›
Market capitalisation of Gaudium IVF and Women Health Ltd is ₹784.28Cr as of 01-Jan-1980.
6. What is the current P/E ratio of Gaudium IVF and Women Health Ltd? ›
The P/E (price-to-earnings) ratio of Gaudium IVF and Women Health Ltd is 34.230.
7. What is the current P/B ratio of Gaudium IVF and Women Health Ltd? ›
The P/B (price-to-book) ratio of Gaudium IVF and Women Health Ltd is 4.470.
8. What is the shareholding pattern of Gaudium IVF and Women Health Ltd? ›
As of 01-Jan-1980, promoters hold 71.292%, foreign institutional investors hold 1.194%, domestic institutional investors hold 2.218%, and the public holds 18.191%.
9. What is the 1-year return of Gaudium IVF and Women Health Ltd? ›
The 1-year return of Gaudium IVF and Women Health Ltd is N/A range.
Open Your Demat Account with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP
Start SIP in Gaudium IVF and Women Health Ltd
Invest systematically in stocks with the PL Capital app